286
Participants
Start Date
March 3, 2020
Primary Completion Date
March 15, 2023
Study Completion Date
July 8, 2023
Clinical management informed by HIV-1 genotypic resistance testing
"The study intervention will consist of the following components:~1. Genotypic resistance testing (GRT);~2. Review of GRT results by an expert committee providing a treatment recommendation;~3. GRT-based decision on further therapy (switch or maintain current ART regimen; choice of regimen); and~4. GRT-informed adherence support."
Seboche Mission Hospital, Seboche
Baylor Clinic Leribe, Hlotse
Baylor Clinic Butha-Buthe, Butha-Buthe
Baylor Clinic Maseru, Maseru
Baylor Clinic Mohale's Hoek, Mohale's Hoek
Baylor Clinic Mokhotlong, Mokhotlong
One-Stop Clinic and Chronic Diseases Clinic (CDCI) at St Francis Referral Hospital, Ifakara
Mbagala Rangi Tatu Hospital, Dar es Salaam
Temeke Regional Referral Hospital, Dar es Salaam
Upendano Dispensary, Dar es Salaam
University Hospital, Basel, Switzerland
OTHER
University of Basel
OTHER
SolidarMed, Partnerships for Health
UNKNOWN
Seboche Mission Hospital
UNKNOWN
Ifakara Health Institute
OTHER
Baylor College of Medicine Children's Foundation
UNKNOWN
Swiss Tropical & Public Health Institute
OTHER